Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes

Z. Nagy, K. Kolev, É Csonka, M. Vastag, R. Machovich

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The action of fibrinolytic enzymes (plasmin, miniplasmin, neutrophil leukocyte elastase) on the blood-brain barrier is investigated. The binding and the effects of the fibrinolytic enzymes are studied in the first tubcultivation of human brain capillary endothelial cells. 125I-labeled plasmin, miniplasmin and neutrophil leukocyte elastase bind to confluent monolayers of cultured endothelial cells with dissociation constants of 1 x 10-8 mol/1, 4.8 x 10-7 mol/1 and 1.8 x 10-8 mol/l, respectively, and the number of binding sites varies between 2.3 x 105 and 7.5 x 106 per cell. Following treatment of the cultured cells with purified and active- site titrated proteases, the changes in morphology of individual cells are analyzed with computerized morphometry. At low concentrations (in nanomolar range) all studied fibrinolytic proteases induce reduction of the cell area; the minimal size is achieved in 20-80 min after the application of an enzyme and the effect is completely reversed in 15 min after its removal. A possible in-vivo consequence of these in-vitro findings is studied in an organ- perfusion model: rat hemisphere is perfused with a protease solution followed by a circulating phase-borne tracer (horse-radish peroxidase). In perfused rat hemisphere, the fibrinolytic enzymes open the blood-brain barrier to the circulation-borne tracer. These results support the concept that fibrinolytic enzymes interact with the brain microvascular endothelium and thus affect the integrity of the blood-brain barrier through active cell contraction.

Original languageEnglish
Pages (from-to)471-478
Number of pages8
JournalBlood Coagulation and Fibrinolysis
Volume9
Issue number6
Publication statusPublished - 1998

Fingerprint

Blood-Brain Barrier
Leukocyte Elastase
Enzymes
Peptide Hydrolases
Fibrinolysin
Cultured Cells
Endothelial Cells
Raphanus
Brain
Peroxidase
Horses
Endothelium
Catalytic Domain
Perfusion
Binding Sites
miniplasmin

Keywords

  • Brain edema
  • Human brain endothelial cells
  • Miniplasmin
  • Neutrophil leukocyte elastase
  • Plasmin

ASJC Scopus subject areas

  • Hematology

Cite this

Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes. / Nagy, Z.; Kolev, K.; Csonka, É; Vastag, M.; Machovich, R.

In: Blood Coagulation and Fibrinolysis, Vol. 9, No. 6, 1998, p. 471-478.

Research output: Contribution to journalArticle

@article{0c9405010de6483a880ea32e96aa325d,
title = "Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes",
abstract = "The action of fibrinolytic enzymes (plasmin, miniplasmin, neutrophil leukocyte elastase) on the blood-brain barrier is investigated. The binding and the effects of the fibrinolytic enzymes are studied in the first tubcultivation of human brain capillary endothelial cells. 125I-labeled plasmin, miniplasmin and neutrophil leukocyte elastase bind to confluent monolayers of cultured endothelial cells with dissociation constants of 1 x 10-8 mol/1, 4.8 x 10-7 mol/1 and 1.8 x 10-8 mol/l, respectively, and the number of binding sites varies between 2.3 x 105 and 7.5 x 106 per cell. Following treatment of the cultured cells with purified and active- site titrated proteases, the changes in morphology of individual cells are analyzed with computerized morphometry. At low concentrations (in nanomolar range) all studied fibrinolytic proteases induce reduction of the cell area; the minimal size is achieved in 20-80 min after the application of an enzyme and the effect is completely reversed in 15 min after its removal. A possible in-vivo consequence of these in-vitro findings is studied in an organ- perfusion model: rat hemisphere is perfused with a protease solution followed by a circulating phase-borne tracer (horse-radish peroxidase). In perfused rat hemisphere, the fibrinolytic enzymes open the blood-brain barrier to the circulation-borne tracer. These results support the concept that fibrinolytic enzymes interact with the brain microvascular endothelium and thus affect the integrity of the blood-brain barrier through active cell contraction.",
keywords = "Brain edema, Human brain endothelial cells, Miniplasmin, Neutrophil leukocyte elastase, Plasmin",
author = "Z. Nagy and K. Kolev and {\'E} Csonka and M. Vastag and R. Machovich",
year = "1998",
language = "English",
volume = "9",
pages = "471--478",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes

AU - Nagy, Z.

AU - Kolev, K.

AU - Csonka, É

AU - Vastag, M.

AU - Machovich, R.

PY - 1998

Y1 - 1998

N2 - The action of fibrinolytic enzymes (plasmin, miniplasmin, neutrophil leukocyte elastase) on the blood-brain barrier is investigated. The binding and the effects of the fibrinolytic enzymes are studied in the first tubcultivation of human brain capillary endothelial cells. 125I-labeled plasmin, miniplasmin and neutrophil leukocyte elastase bind to confluent monolayers of cultured endothelial cells with dissociation constants of 1 x 10-8 mol/1, 4.8 x 10-7 mol/1 and 1.8 x 10-8 mol/l, respectively, and the number of binding sites varies between 2.3 x 105 and 7.5 x 106 per cell. Following treatment of the cultured cells with purified and active- site titrated proteases, the changes in morphology of individual cells are analyzed with computerized morphometry. At low concentrations (in nanomolar range) all studied fibrinolytic proteases induce reduction of the cell area; the minimal size is achieved in 20-80 min after the application of an enzyme and the effect is completely reversed in 15 min after its removal. A possible in-vivo consequence of these in-vitro findings is studied in an organ- perfusion model: rat hemisphere is perfused with a protease solution followed by a circulating phase-borne tracer (horse-radish peroxidase). In perfused rat hemisphere, the fibrinolytic enzymes open the blood-brain barrier to the circulation-borne tracer. These results support the concept that fibrinolytic enzymes interact with the brain microvascular endothelium and thus affect the integrity of the blood-brain barrier through active cell contraction.

AB - The action of fibrinolytic enzymes (plasmin, miniplasmin, neutrophil leukocyte elastase) on the blood-brain barrier is investigated. The binding and the effects of the fibrinolytic enzymes are studied in the first tubcultivation of human brain capillary endothelial cells. 125I-labeled plasmin, miniplasmin and neutrophil leukocyte elastase bind to confluent monolayers of cultured endothelial cells with dissociation constants of 1 x 10-8 mol/1, 4.8 x 10-7 mol/1 and 1.8 x 10-8 mol/l, respectively, and the number of binding sites varies between 2.3 x 105 and 7.5 x 106 per cell. Following treatment of the cultured cells with purified and active- site titrated proteases, the changes in morphology of individual cells are analyzed with computerized morphometry. At low concentrations (in nanomolar range) all studied fibrinolytic proteases induce reduction of the cell area; the minimal size is achieved in 20-80 min after the application of an enzyme and the effect is completely reversed in 15 min after its removal. A possible in-vivo consequence of these in-vitro findings is studied in an organ- perfusion model: rat hemisphere is perfused with a protease solution followed by a circulating phase-borne tracer (horse-radish peroxidase). In perfused rat hemisphere, the fibrinolytic enzymes open the blood-brain barrier to the circulation-borne tracer. These results support the concept that fibrinolytic enzymes interact with the brain microvascular endothelium and thus affect the integrity of the blood-brain barrier through active cell contraction.

KW - Brain edema

KW - Human brain endothelial cells

KW - Miniplasmin

KW - Neutrophil leukocyte elastase

KW - Plasmin

UR - http://www.scopus.com/inward/record.url?scp=0031793786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031793786&partnerID=8YFLogxK

M3 - Article

C2 - 9818996

AN - SCOPUS:0031793786

VL - 9

SP - 471

EP - 478

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 6

ER -